Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 03, 2021

SELL
$34.07 - $39.94 $4,633 - $5,431
-136 Closed
0 $0
Q3 2020

Nov 06, 2020

SELL
$38.11 - $42.99 $22,523 - $25,407
-591 Reduced 81.29%
136 $5,000
Q2 2020

Jul 17, 2020

BUY
$37.87 - $43.58 $189 - $217
5 Added 0.69%
727 $30,000
Q1 2020

May 04, 2020

SELL
$32.47 - $48.83 $97 - $146
-3 Reduced 0.41%
722 $27,000
Q4 2019

Feb 04, 2020

BUY
$42.0 - $48.25 $5,250 - $6,031
125 Added 20.83%
725 $34,000
Q3 2019

Nov 05, 2019

BUY
$40.46 - $43.52 $24,276 - $26,112
600 New
600 $26,000
Q1 2019

Apr 16, 2019

SELL
$38.57 - $42.69 $539 - $597
-14 Closed
0 $0
Q4 2018

Feb 11, 2019

BUY
$37.8 - $42.69 $529 - $597
14 New
14 $1,000
Q1 2018

May 01, 2018

SELL
$36.18 - $40.15 $34,732 - $38,544
-960 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$35.34 - $41.9 $33,926 - $40,224
960
960 $34,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $67.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Prime Capital Investment Advisors, LLC Portfolio

Follow Prime Capital Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prime Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prime Capital Investment Advisors, LLC with notifications on news.